Dr. Dimitri Koutzoumis l Infectious Diseases
| Best Researcher Award

Dr. Dimitri Koutzoumis is an accomplished biomedical scientist with extensive expertise in neuroscience, neurodegeneration, and translational research, focusing on dopamine signaling and gut-brain interactions. His doctoral research at the University of Florida examined the role of gut microbiota and bacterial metabolites in modulating dopamine neuron vulnerability, demonstrating how microbiome-induced changes in immune cell populations influence neurodegenerative processes. During his postdoctoral tenure at The City College of New York, he conducted advanced immunohistochemistry, cytokine profiling, and behavioral assays in Parkinson’s disease models, combining molecular and functional approaches to elucidate mechanisms of neuroinflammation and motor deficits. At Sanaria Inc., he applied his skills to vaccine development, including cryopreservation of malaria sporozoites, in vitro potency assays, and GMP-compliant quality management, bridging academic research with industry applications. His notable publication, “Characterizing Dopamine Transporter Mediated Uptake and Efflux in Brain Slices: A New Approach”, highlights innovative methods for studying transporter dynamics in neural tissue. Dr. Koutzoumis has 131 citations across 4 documents, an h-index of 3, and is indexed under Scopus Author ID 57188503800, reflecting his impact on the field. With a strong foundation in molecular biology, pharmacology, and translational science, he continues to advance understanding of neurodegenerative mechanisms while contributing to practical biomedical innovations.